Travere Therapeutics, Inc. (TVTX)
NASDAQ·Healthcare·Biotechnology
$41.12
+0.76%
Mkt Cap $3.74B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 19, 2026 | $144.55M | $129.69M | -10.28% | $0.03 | $0.03 | +0.00% | — | — |
| Q4 2025 Oct 30, 2025 | $146.98M | $164.86M | +12.16% | -$0.31 | $0.28 | +190.32% | — | — |
| Q3 2025 Aug 6, 2025 | $99.55M | $114.45M | +14.97% | -$0.28 | -$0.14 | +50.00% | — | — |
| Q2 2025 May 1, 2025 | $88.80M | $81.73M | -7.96% | -$0.55 | -$0.47 | +14.55% | — | — |
| Q1 2025 Feb 20, 2025 | $72.38M | $74.79M | +3.33% | -$0.58 | -$0.73 | -25.86% | — | — |
| Q4 2024 Oct 31, 2024 | $71.44M | $62.90M | -11.96% | -$0.70 | -$0.70 | +0.00% | — | — |
| Q3 2024 Aug 1, 2024 | $57.77M | $54.12M | -6.33% | -$0.87 | -$0.90 | -3.45% | — | — |
| Q2 2024 May 6, 2024 | $42.85M | $41.37M | -3.44% | -$0.98 | -$1.76 | -79.59% | — | — |
| Q1 2024 Feb 15, 2024 | $41.51M | $45.06M | +8.55% | -$1.27 | -$1.16 | +8.66% | — | — |
| Q4 2023 Nov 7, 2023 | $117.31M | $37.09M | -68.38% | -$1.09 | -$1.17 | -7.34% | — | — |
| Q3 2023 Aug 3, 2023 | $53.71M | $59.70M | +11.15% | -$1.16 | -$1.13 | +2.59% | — | — |
| Q2 2023 May 4, 2023 | $50.61M | $56.99M | +12.61% | -$1.18 | -$1.27 | -7.63% | — | — |
| Q1 2023 Feb 23, 2023 | $53.01M | $55.87M | +5.38% | -$1.04 | -$1.03 | +0.96% | — | — |
| Q4 2022 Oct 27, 2022 | $54.12M | $53.50M | -1.15% | -$0.97 | -$1.09 | -12.37% | — | — |
| Q3 2022 Aug 4, 2022 | $49.63M | $54.17M | +9.14% | -$0.94 | -$1.05 | -11.70% | — | — |
| Q2 2022 May 5, 2022 | $52.19M | $48.49M | -7.10% | -$0.85 | -$1.20 | -41.18% | — | — |
| Q1 2022 Feb 24, 2022 | $57.80M | $57.25M | -0.95% | -$0.72 | -$0.84 | -16.67% | — | — |
| Q4 2021 Oct 28, 2021 | $52.64M | $68.22M | +29.59% | -$0.72 | -$0.59 | +18.06% | — | — |
| Q3 2021 Jul 29, 2021 | $54.62M | $54.62M | +0.00% | -$0.73 | -$0.64 | +12.33% | — | — |
| Q2 2021 May 6, 2021 | $36.10M | $47.41M | +31.31% | -$0.56 | -$0.96 | -71.43% | — | — |